Powder: -20°C for 3 years | In solvent: -80°C for 1 year
RG14620 (Tyrphostin RG14620)是一种EGFR 抑制剂,IC50值为3 μM。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
2 mg | ¥ 259 | 现货 | ||
5 mg | ¥ 443 | 现货 | ||
10 mg | ¥ 659 | 现货 | ||
25 mg | ¥ 1,280 | 现货 | ||
50 mg | ¥ 2,480 | 现货 | ||
100 mg | ¥ 3,690 | 现货 | ||
500 mg | ¥ 8,250 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 490 | 现货 |
产品描述 | RG14620 (Tyrphostin RG14620) is an epidermal growth factor receptor (EGFR) inhibitor. |
靶点活性 | EGFR:3 μM. |
体外活性 | RG-14620 inhibits colony formation and DNA synthesis by HER 14 cells, which are stimulated by 50 ng/mL EGF, in a dose-dependent manner. The IC50s for RG-14620 are 3 μM for HER 14 colony formation and 1 pM for HER 14 DNA synthesis[1]. RG-14620 also suppresses colony formation and DNA synthesis by EGF-stimulated MH-85 cells in a dose-dependent manner. The IC50s for RG-14620 on MH-85 cells are 4 μM for colony formation and 1.25 μM for DNA synthesis[1]. |
体内活性 | RG-14620, at a dose of 200 μg/mouse/day inhibits MH-85 tumor growth in nude mice. Mice show less cachexia and hypercalcemia, eat more food, and are more active than untreated MH-85 tumor-bearing animals[1]. |
细胞实验 | RG14620 is dissolved in 100% DMSO and diluted with the culture medium before addition to the cells. MH-85 and HER 14 cells are cultured in the medium in the presence or absence of increasing concentrations of RG-13022 or RG-14620 for 10 days. At the end of culture, the cells are fixed with 4% (v/v) formaldehyde in calcium-magnesium-free phosphate-buffered saline for 15 min at room temperature and stained with hematoxylin. Numbers of colonies including more than 20 cells in each well are counted under the microscope[1]. |
别名 | Tyrphostin RG14620, RG 14620 |
分子量 | 275.13 |
分子式 | C14H8Cl2N2 |
CAS No. | 136831-49-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 18.33 mg/mL (66.64 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 3.6346 mL | 18.1732 mL | 36.3465 mL | 90.8661 mL |
5 mM | 0.7269 mL | 3.6346 mL | 7.2693 mL | 18.1732 mL | |
10 mM | 0.3635 mL | 1.8173 mL | 3.6346 mL | 9.0866 mL | |
20 mM | 0.1817 mL | 0.9087 mL | 1.8173 mL | 4.5433 mL | |
50 mM | 0.0727 mL | 0.3635 mL | 0.7269 mL | 1.8173 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
RG14620 136831-49-7 Angiogenesis JAK/STAT signaling Tyrosine Kinase/Adaptors EGFR HER Tyrphostin RG-14620 HER1 inhibit RG-14620 Tyrphostin RG14620 RG 14620 Tyrphostin RG 14620 Inhibitor Epidermal growth factor receptor ErbB-1 inhibitor